Literature DB >> 21518836

Molecular mechanism of renal tubular secretion of the antimalarial drug chloroquine.

Fabian Müller1, Jörg König, Hartmut Glaeser, Ingrid Schmidt, Oliver Zolk, Martin F Fromm, Renke Maas.   

Abstract

The antimalarial drug chloroquine is eliminated to a significant extent by renal tubular secretion. The molecular mechanism of renal chloroquine secretion remains unknown. We hypothesized that organic cation transporter 2 (OCT2) and multidrug and toxin extrusion protein 1 (MATE1), localized in the basolateral and luminal membranes of proximal tubule cells, respectively, are involved in chloroquine transport. The interaction of chloroquine with both transporters was investigated using single-transfected human embryonic kidney 293 (HEK293)-MATE1 cells in uptake experiments and single-transfected Madin-Darby canine kidney II (MDCK)-OCT2 and MDCK-MATE1 cells as well as double-transfected MDCK-OCT2-MATE1 cells grown as polarized monolayers on transwell filters. In HEK293-MATE1 cells, chloroquine competitively inhibited MATE1-mediated metformin uptake (K(i) = 2.8 μM). Cellular accumulation of chloroquine was significantly lower (P < 0.001) and transcellular chloroquine transport was significantly increased (P < 0.001) in MDCK-MATE1 and MDCK-OCT2-MATE1 cells compared to vector control cells after basal addition of chloroquine (0.1 to 10 μM). In contrast, no difference in cellular accumulation or transcellular transport of chloroquine was observed between MDCK-OCT2 and vector control cells. In line with an oppositely directed proton gradient acting as a driving force for MATE1, basal-to-apical transport of chloroquine by MDCK-OCT2-MATE1 cells increased with decreasing apical pH from 7.8 to 6.0. Transcellular transport of chloroquine by MDCK-OCT2-MATE1 cells was inhibited by cimetidine, trimethoprim, and amitriptyline. Our data demonstrate that chloroquine is a substrate and potent competitive inhibitor of MATE1, whereas OCT2 seems to play no role in chloroquine uptake. Concomitantly administered MATE1 inhibitors are likely to modify the renal secretion of chloroquine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21518836      PMCID: PMC3122445          DOI: 10.1128/AAC.01835-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  45 in total

1.  The determination of enzyme inhibitor constants.

Authors:  M DIXON
Journal:  Biochem J       Date:  1953-08       Impact factor: 3.857

Review 2.  Effectiveness of antimalarial drugs.

Authors:  J Kevin Baird
Journal:  N Engl J Med       Date:  2005-04-14       Impact factor: 91.245

3.  THE INFLUENCE OF ORALLY ADMINISTERED ALKALI AND ACID ON THE RENAL EXCRETION OF QUINACRINE, CHLOROQUINE AND SANTOQUINE.

Authors:  J W Jailer; M Rosenfeld; J A Shannon
Journal:  J Clin Invest       Date:  1947-11       Impact factor: 14.808

4.  Gene expression levels and immunolocalization of organic ion transporters in the human kidney.

Authors:  Hideyuki Motohashi; Yuji Sakurai; Hideyuki Saito; Satohiro Masuda; Yumiko Urakami; Maki Goto; Atsushi Fukatsu; Osamu Ogawa; Ken-Ichi Inui
Journal:  J Am Soc Nephrol       Date:  2002-04       Impact factor: 10.121

5.  In vitro activity of chloroquine, the two enantiomers of chloroquine, desethylchloroquine and pyronaridine against Plasmodium falciparum.

Authors:  S Fu; A Björkman; B Wåhlin; D Ofori-Adjei; O Ericsson; F Sjöqvist
Journal:  Br J Clin Pharmacol       Date:  1986-07       Impact factor: 4.335

6.  Chloroquine elimination in humans: effect of low-dose cimetidine.

Authors:  E I Ette; E A Brown-Awala; E E Essien
Journal:  J Clin Pharmacol       Date:  1987-10       Impact factor: 3.126

7.  Human multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter: functional characterization, interaction with OCT2 (SLC22A2), and single nucleotide polymorphisms.

Authors:  Henriette E Meyer zu Schwabedissen; Celine Verstuyft; Heyo K Kroemer; Laurent Becquemont; Richard B Kim
Journal:  Am J Physiol Renal Physiol       Date:  2010-01-06

8.  Population pharmacokinetics of chloroquine and sulfadoxine and treatment response in children with malaria: suggestions for an improved dose regimen.

Authors:  Celestino Obua; Urban Hellgren; Muhammed Ntale; Lars L Gustafsson; Jasper W Ogwal-Okeng; Toufigh Gordi; Markus Jerling
Journal:  Br J Clin Pharmacol       Date:  2008-02-20       Impact factor: 4.335

9.  Pharmacokinetics of chloroquine in renal insufficiency.

Authors:  L A Salako; O Walker; A O Iyun
Journal:  Afr J Med Med Sci       Date:  1984 Sep-Dec

10.  Targeted disruption of the multidrug and toxin extrusion 1 (mate1) gene in mice reduces renal secretion of metformin.

Authors:  Masahiro Tsuda; Tomohiro Terada; Tomoyuki Mizuno; Toshiya Katsura; Jin Shimakura; Ken-ichi Inui
Journal:  Mol Pharmacol       Date:  2009-03-30       Impact factor: 4.436

View more
  19 in total

1.  Downregulation of Organic Anion Transporting Polypeptide (OATP) 1B1 Transport Function by Lysosomotropic Drug Chloroquine: Implication in OATP-Mediated Drug-Drug Interactions.

Authors:  Khondoker Alam; Sonia Pahwa; Xueying Wang; Pengyue Zhang; Kai Ding; Alaa H Abuznait; Lang Li; Wei Yue
Journal:  Mol Pharm       Date:  2016-02-01       Impact factor: 4.939

2.  Role of ABC and Solute Carrier Transporters in the Placental Transport of Lamivudine.

Authors:  Martina Ceckova; Josef Reznicek; Zuzana Ptackova; Lukas Cerveny; Fabian Müller; Marian Kacerovsky; Martin F Fromm; Jocelyn D Glazier; Frantisek Staud
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

3.  Role of OCT2 and MATE1 in renal disposition and toxicity of nitidine chloride.

Authors:  L P Li; F F Song; Y Y Weng; X Yang; K Wang; H M Lei; J Ma; H Zhou; H D Jiang
Journal:  Br J Pharmacol       Date:  2016-07-09       Impact factor: 8.739

Review 4.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

5.  Simulated Assessment of Pharmacokinetically Guided Dosing for Investigational Treatments of Pediatric Patients With Coronavirus Disease 2019.

Authors:  Anil R Maharaj; Huali Wu; Christoph P Hornik; Stephen J Balevic; Chi D Hornik; P Brian Smith; Daniel Gonzalez; Kanecia O Zimmerman; Daniel K Benjamin; Michael Cohen-Wolkowiez
Journal:  JAMA Pediatr       Date:  2020-10-05       Impact factor: 16.193

6.  Atenolol Renal Secretion Is Mediated by Human Organic Cation Transporter 2 and Multidrug and Toxin Extrusion Proteins.

Authors:  Jia Yin; Haichuan Duan; Yoshiyuki Shirasaka; Bhagwat Prasad; Joanne Wang
Journal:  Drug Metab Dispos       Date:  2015-09-15       Impact factor: 3.922

7.  N(1)-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin-trimethoprim interaction.

Authors:  Fabian Müller; Constanza A Pontones; Bertold Renner; Maren Mieth; Eva Hoier; Daniel Auge; Renke Maas; Oliver Zolk; Martin F Fromm
Journal:  Eur J Clin Pharmacol       Date:  2014-10-22       Impact factor: 2.953

8.  Pigmented-MDCK (P-MDCK) cell line with tunable melanin expression: an in vitro model for the outer blood-retinal barrier.

Authors:  Rajendra S Kadam; Robert I Scheinman; Uday B Kompella
Journal:  Mol Pharm       Date:  2012-10-15       Impact factor: 4.939

9.  Multiple Drug Transporters Are Involved in Renal Secretion of Entecavir.

Authors:  Xi Yang; Zhiyuan Ma; Sisi Zhou; Yayun Weng; Hongmei Lei; Su Zeng; Liping Li; Huidi Jiang
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

10.  Trimethoprim-metformin interaction and its genetic modulation by OCT2 and MATE1 transporters.

Authors:  Barbara Grün; Michael K Kiessling; Jürgen Burhenne; Klaus-Dieter Riedel; Johanna Weiss; Geraldine Rauch; Walter E Haefeli; David Czock
Journal:  Br J Clin Pharmacol       Date:  2013-11       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.